Research on tumor-infiltrating lymphocyte therapy in melanoma is being explored, with some studies examining its prognostic value and potential as a form of immunotherapy. The therapy's readiness for widespread use is being considered, with some outlets questioning whether it is ready for "prime time". The topic is being discussed in various scientific journals, including the British Journal of Cancer and Nature.